Fermenta Biotech Limited (FERMENTA) Share Price
NSE · Healthcare · Drug Manufacturers - Specialty & Generic · ISIN INE225B01021
Key metrics
- Market Cap
- —
- P/E Ratio
- 25.52
- EPS
- 20.4
- Book Value
- 136.1
- P/B Ratio
- 3.57
- ROE
- 17.92%
- ROCE
- 16.12%
- Debt / Equity
- 0.28
- Net Margin
- 13.71%
- Revenue Growth
- 12.09%
- Profit Growth
- -6.63%
- Dividend Yield
- —
- 52W High
- ₹529.80
- 52W Low
- ₹442.05
- Market Cap Band
- —
- Face Value
- 5
Ratios computed from the annual results period ending 2026-03-31.
About Fermenta Biotech Limited
Fermenta Biotech Limited, together with its subsidiaries, engages in the manufacturing and marketing of chemicals, bulk drugs, enzymes, pharmaceutical formulations, and environmental solution products in India, Europe, the United States, and internationally. It operates through Chemicals/Bulk Drug and Property segments. The company offers vitamin D3, including crystalline oil, resin oil, cold water dispersible, and feed grade powder for injectables, soft gel capsules, premixes, food and beverage fortification applications; and vitamin K1, vitamin E50, phenyramidol and silicon dioxide, and fish oil cholesterol. It also provides fortified rice kernel; and Fermase PS 250 and penicillin G acylase used in manufacturing processes of various antibiotics. In addition, the company offers design, engineering, procurement, and construction of wastewater treatment plants, STPs, and ETPs, as well as operation and maintenance services. Further, it is involved in property development business; and renting and selling of properties. The company was formerly known as DIL Limited. Fermenta Biotech Limited was incorporated in 1951 and is based in Thane, India.
- Headquarters
- Thane, India
- Employees
- 630
- Promoter Holding
- 70.72%
The full Fermenta Biotech Limited analysis
Create a free account to open the complete FERMENTA deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.